2. Socransky SS. 1977; Microbiology of periodontal disease - present status and future considerations. J Periodontol. 48:497–504. DOI:
10.1902/jop.1977.48.9.497. PMID:
333085.
7. Wijnsma KL, Veissi ST, de Wijs S, van der Velden T, Volokhina EB, Wagener FADTG, van de Kar NCAJ, van den Heuvel LP. 2020; Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome. Front Immunol. 11:547406. DOI:
10.3389/fimmu.2020.547406. PMID:
33414780. PMCID:
PMC7783363.
8. Muller-Eberhard U, Fraig M. 1993; Bioactivity of heme and its containment. Am J Hematol. 42:59–62. DOI:
10.1002/ajh.2830420112. PMID:
8416298.
9. Chaudhry SR, Hafez A, Rezai Jahromi B, Kinfe TM, Lamprecht A, Niemela M, Muhammad S. 2018; Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH). Int J Mol Sci. 19:2035. DOI:
10.3390/ijms19072035. PMID:
30011792. PMCID:
PMC6073937.
10. Liu X, Olczak T, Guo HC, Dixon DW, Genco CA. 2006; Identification of amino acid residues involved in heme binding and hemoprotein utilization in the Porphyromonas gingivalis heme receptor HmuR. Infect Immun. 74:1222–32. DOI:
10.1128/IAI.74.2.1222-1232.2006. PMID:
16428772. PMCID:
PMC1360300.
12. Al-Qutub MN, Braham PH, Karimi-Naser LM, Liu X, Genco CA, Darveau RP. 2006; Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infect Immun. 74:4474–85. DOI:
10.1128/IAI.01924-05. PMID:
16861633. PMCID:
PMC1539574.
13. Lee HR, Rhyu IC, Kim HD, Jun HK, Min BM, Lee SH, Choi BK. 2011; In-vivo-induced antigenic determinants of Fusobacterium nucleatum subsp. nucleatum. Mol Oral Microbiol. 26:164–72. DOI:
10.1111/j.2041-1014.2010.00594.x. PMID:
21375706.
14. Yu F, Anaya C, Lewis JP. 2007; Outer membrane proteome of Prevotella intermedia 17: identification of thioredoxin and iron-repressible hemin uptake loci. Proteomics. 7:403–12. DOI:
10.1002/pmic.200600441. PMID:
17177252.
15. Aguilera O, Andrés MT, Heath J, Fierro JF, Douglas CW. 1998; Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens. FEMS Immunol Med Microbiol. 21:29–36. DOI:
10.1111/j.1574-695X.1998.tb01146.x. PMID:
9657318.
16. Liu LY, McGreor N, Wong BK, Butt H, Darby IB. 2016; The association between clinical periodontal parameters and free haem concentration within the gingival crevicular fluid: a pilot study. J Periodontal Res. 51:86–94. DOI:
10.1111/jre.12286. PMID:
26094689.
17. Loesche WJ. 1976; Chemotherapy of dental plaque infections. Oral Sci Rev. 9:65–107. PMID:
1067529.
19. Olczak T, Simpson W, Liu X, Genco CA. 2005; Iron and heme utilization in Porphyromonas gingivalis. FEMS Microbiol Rev. 29:119–44. DOI:
10.1016/j.femsre.2004.09.001. PMID:
15652979.
20. Lee SH, Baek DH. 2014; Effects of Streptococcus thermophilus on volatile sulfur compounds produced by Porphyromonas gingivalis. Arch Oral Biol. 59:1205–10. DOI:
10.1016/j.archoralbio.2014.07.006. PMID:
25105253.
21. Lee SH, Baek DH. 2013; Characteristics of Porphyromonas gingivalis lipopolysaccharide in co-culture with Fusobacterium nucleatum. Mol Oral Microbiol. 28:230–8. DOI:
10.1111/omi.12020. PMID:
23347381.